Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency

References

• Miller WL. Genetics, diagnosis and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 78: 241–6.
   Google Scholar
• Jääskeläinen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997; 82: 3293–7.
   Google Scholar
• New MI. Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Am J Med 1995; 98: 2S–8S.
   Google Scholar
• Klingensmith GJ, Garcia SC, Jones HW Jr, Migeon CJ, Blizzard RM. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation and fertility. J Pediatr 1977; 90: 996–1004.
   Google Scholar
• Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178–82.
   Google Scholar
• Feldman S, Billaud L, Thalabard J-C, Raux-Demay M-C, Mowszowicz I, Kuttenn F et al. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 74: 635–9.
   Google Scholar
• Helleday J, Siwers B, Ritzen ME, Carlström K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 76: 933–6.
   Google Scholar
• Ehrhardt AA, Evers K, Money J. Influence of androgen and some aspects of sexually dimorphic behavior in women with the late-treated adrenogenital syndrome. Johns Hopkins Med J 1968; 123: 115–22.
   Google Scholar
• Kuhnle U, Bullinger M, Schwarz HP, Knorr D. Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality- of-life evaluation. J Steroid Biochem Mol Biol 1993; 45: 123–6.
   Google Scholar
• Holmes-Walker DJ, Conway GS, Honour JW, Rumsby G, Jacobs HS. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 1995; 43: 291–6.
   Google Scholar
• Lucis OJ, Hobkirk R, Hollenberg CH, MacDonald SA, Blahey P. Polycystic ovaries associated with congenital adrenal hyperplasia. Can Med Assoc J 1966; 94: 1–7.
   Google Scholar
• Hague WM, Adams J, Rodda C, Brook CG, de Bryun R, Grant DB et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol 1990; 33: 501–10.
   Google Scholar
• Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrog- enism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322–53.
   Google Scholar
• Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL et al. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence of perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79: 1328–33.
   Google Scholar
• Belgorosky A, Chahin S, Rivarola MA. Elevation of serum luteinizing hormone levels during hydrocortisone treatment in infant girls with 21-hydroxylase deficiency. Acta Paediatr 1996; 85: 1172–5.
   Google Scholar
• Van Wyk JJ, Gunther DF, Ritzen ME, Wedell A, Cutler GB, Migeon CJ et al. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996; 81: 3180–90.
   Google Scholar
• Lo JC, Schwitzgebel VM, Tyrrel JB, Fitzgerald PA, Kaplan SL, Conte FA et al. Normal female infants born to mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 930–6.
   Google Scholar
• Statistics Finland. Population Structure 1995. Helsinki: Statistics Finland, 1996: 66.
   Google Scholar